We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal

Download Mobile App




Pioneering AI Automatically Diagnoses Lung Diseases from X-Ray Images

By HospiMedica International staff writers
Posted on 08 Nov 2022
Print article
Image: Artificial intelligence could help ease hospital pressures (Photo courtesy of University of the West of Scotland)
Image: Artificial intelligence could help ease hospital pressures (Photo courtesy of University of the West of Scotland)

Tuberculosis and pneumonia – potentially serious infections which mainly affect the lungs –often require a combination of different diagnostic tests– such as CT scans, blood tests, X-rays, and ultrasounds. These tests can be expensive, with often lengthy waiting times for results. Now, pioneering artificial intelligence (AI) which automatically diagnoses lung diseases – such as tuberculosis and pneumonia – from X-ray images could ease winter pressures on hospitals.

The revolutionary technology developed by researchers at University of the West of Scotland (Scotland, UK) was originally created to quickly detect COVID-19 from X-ray images but has been proven to automatically identify a range of different lung diseases in a matter of minutes, with around 98% accuracy. It is hoped that the technology can be used to help relieve strain on pressured hospital departments through the quick and accurate detection of disease – freeing up radiographers continuously in high demand; reducing waiting times for test results; and creating efficiencies within the testing process.

The state-of-the-art technique utilizes X-ray technology, comparing scans to a database of thousands of images from patients with pneumonia, tuberculosis and COVID. It then uses a process known as deep convolutional neural network – an algorithm typically used to analyze visual imagery – to make a diagnosis. During an extensive testing phase, the technique proved to be 98% accurate. Researchers at UWS are now exploring the suitability of the technology in detecting other diseases using X-ray images, such as cancer.

“There is no doubt that hospital departments across the globe are under pressure and the outbreak of COVID-19 exacerbated this, adding further strain to pressured departments and staff. There is a real need for technology that can help ease some of these pressures and detect a range of different diseases quickly and accurately, helping free up valuable staff time,” said Professor Ramzan, Director of the Affective and Human Computing for SMART Environments Research Centre at UWS, who led the development of the technology. “X-ray imaging is a relatively cheap and accessible diagnostic tool that already assists in the diagnosis of various conditions, including pneumonia, tuberculosis and COVID-19. Recent advances in AI have made automated diagnosis using chest X-ray scans a very real prospect in medical settings.”

Related Links:
University of the West of Scotland

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
1.5T MRI Scanner
MAGNETOM Amira

Print article

Channels

Critical Care

view channel
Image: Peerbridge Cor is a 3-lead, 2-channel wireless AECG that simplifies the testing and diagnostic process (Photo courtesy of Peerbridge Health)

First-of-its-Kind Trial to Measure Ejection Fraction Severity Directly from AI-Enabled Remote ECG Wearable

Echocardiograms are a standard diagnostic tool to measure ejection fraction but require a clinical setting for administration. This can pose challenges such as scheduling delays, staffing shortages, accessibility... Read more

Surgical Techniques

view channel
Image: Fixation screws for ligament to bone repair (Photo courtesy of 4D Medicine)

Novel Biomaterial Platform Opens Up New Possibilities for Implants and Devices

Resorbable biomaterials, crucial for implantable medical devices, have seen little innovation over decades. Materials like Polylactic Acid (PLA), Polycaprolactone (PCL), and Poly Lactic-co-Glycolic Acid... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: POCT offers cost-effective, accessible, and immediate diagnostic solutions (Photo courtesy of Flinders University)

POCT for Infectious Diseases Delivers Laboratory Equivalent Pathology Results

On-site pathology tests for infectious diseases in rural and remote locations can achieve the same level of reliability and accuracy as those conducted in hospital laboratories, a recent study suggests.... Read more

Business

view channel
Image: The Innovalve transseptal delivery system is designed to enable safe deployment of the Innovalve implant (Photo courtesy of Innovalve Bio)

Edwards Lifesciences Acquires Sheba Medical’s Innovalve Bio Medical

Edwards Lifesciences (Irvine, CA, USA), a leading company in medical innovations for structural heart disease and critical care, has acquired Innovalve Bio Medical LTD. (Ramat Gan, Israel), an early-stage... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.